{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:00:27Z","timestamp":1787166027600,"version":"build-2736575974"},"reference-count":162,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T00:00:00Z","timestamp":1713830400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100018996","name":"HEAL-Link","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100018996","id-type":"DOI","asserted-by":"crossref"}]},{"name":"University of Thessaly Central Library"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Pain Headache Rep"],"published-print":{"date-parts":[[2024,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Purpose of Review<\/jats:title>\n                    <jats:p>Fibromyalgia syndrome (FMS) is a disease of unknown pathophysiology, with the diagnosis being based on a set of clinical criteria. Proteomic analysis can provide significant biological information for the pathophysiology of the disease but may also reveal biomarkers for diagnosis or therapeutic targets. The present systematic review aims to synthesize the evidence regarding the proteome of adult patients with FMS using data from observational studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Recent Findings<\/jats:title>\n                    <jats:p>An extensive literature search was conducted in MEDLINE\/PubMed, CENTRAL, and clinicaltrials.gov from inception until November 2022. The study protocol was published in OSF. Two independent reviewers evaluated the studies and extracted data. The quality of studies was assessed using the modified Newcastle\u2013Ottawa scale adjusted for proteomic research. Ten studies fulfilled the protocol criteria, identifying 3328 proteins, 145 of which were differentially expressed among patients with FMS against controls. The proteins were identified in plasma, serum, cerebrospinal fluid, and saliva samples. The control groups included healthy individuals and patients with pain (inflammatory and non-inflammatory).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Summary<\/jats:title>\n                    <jats:p>The most important proteins identified involved transferrin, \u03b1-, \u03b2-, and \u03b3-fibrinogen chains, profilin-1, transaldolase, PGAM1, apolipoprotein-C3, complement C4A and C1QC, immunoglobin parts, and acute phase reactants. Weak correlations were observed between proteins and pain sensation, or quality of life scales, apart from the association of transferrin and a2-macroglobulin with moderate-to-severe pain sensation. The quality of included studies was moderate-to-good. FMS appears to be related to protein dysregulation in the complement and coagulation cascades and the metabolism of iron. Several proteins may be dysregulated due to the excessive oxidative stress response.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11916-024-01244-4","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T09:01:48Z","timestamp":1713862908000},"page":"565-586","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Proteomics in Patients with Fibromyalgia Syndrome: A Systematic Review of Observational Studies"],"prefix":"10.1007","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0009-0006-0815-4700","authenticated-orcid":false,"given":"Arriana","family":"Gkouvi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8900-7281","authenticated-orcid":false,"given":"Sotirios G.","family":"Tsiogkas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9697-7902","authenticated-orcid":false,"given":"Dimitrios P.","family":"Bogdanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1893-937X","authenticated-orcid":false,"given":"Helen","family":"Gika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5005-1995","authenticated-orcid":false,"given":"Dimitrios G.","family":"Goulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4167-6595","authenticated-orcid":false,"given":"Maria G.","family":"Grammatikopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,4,23]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1097\/j.pain.0000000000002927","volume":"164","author":"C Mueller","year":"2023","unstructured":"Mueller C, Fang Y-HD, Jones C, McConathy JE, Raman F, Lapi SE, et al. Evidence of neuroinflammation in fibromyalgia syndrome: a [18F]DPA-714\u00a0positron emission tomography study. Pain. 2023;164:2285\u201395.","journal-title":"Pain"},{"key":"1244_CR2","doi-asserted-by":"publisher","first-page":"1416","DOI":"10.1097\/j.pain.0000000000002857","volume":"164","author":"E Beiner","year":"2023","unstructured":"Beiner E, Lucas V, Reichert J, Buhai D-V, Jesinghaus M, Vock S, et al. Stress biomarkers in individuals with fibromyalgia syndrome: a systematic review with meta-analysis. Pain. 2023;164:1416\u201327.","journal-title":"Pain"},{"key":"1244_CR3","doi-asserted-by":"publisher","first-page":"ITC33","DOI":"10.7326\/AITC202003030","volume":"172","author":"MJ Bair","year":"2020","unstructured":"Bair MJ, Krebs EE. Fibromyalgia. Ann Intern Med. 2020;172:ITC33\u201348.","journal-title":"Ann Intern Med"},{"key":"1244_CR4","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.medcli.2017.06.008","volume":"149","author":"A Cabo-Meseguer","year":"2017","unstructured":"Cabo-Meseguer A, Cerd\u00e1-Olmedo G, Trillo-Mata JL. Fibromyalgia: prevalence, epidemiologic profiles and economic costs. Med Clin (Barc). 2017;149:441\u20138.","journal-title":"Med Clin (Barc)"},{"key":"1244_CR5","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.1007\/s00296-017-3725-2","volume":"37","author":"F Heidari","year":"2017","unstructured":"Heidari F, Afshari M, Moosazadeh M. Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis. Rheumatol Int. 2017;37:1527\u201339.","journal-title":"Rheumatol Int"},{"key":"1244_CR6","doi-asserted-by":"publisher","first-page":"495","DOI":"10.3109\/07853890.2011.595734","volume":"43","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, H\u00e4user W. Fibromyalgia diagnosis and diagnostic criteria. Ann Med. 2011;43:495\u2013502.","journal-title":"Ann Med"},{"key":"1244_CR7","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/art.1780330203","volume":"33","author":"F Wolfe","year":"1990","unstructured":"Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum. 1990;33:160\u201372.","journal-title":"Arthritis Rheum"},{"key":"1244_CR8","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/j.semarthrit.2016.08.012","volume":"46","author":"F Wolfe","year":"2016","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, H\u00e4user W, Katz RL, et al. 2016 revisions to the 2010\/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum. 2016;46:319\u201329.","journal-title":"Semin Arthritis Rheum"},{"key":"1244_CR9","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.3899\/jrheum.100594","volume":"38","author":"F Wolfe","year":"2011","unstructured":"Wolfe F, Clauw DJ, Fitzcharles M-A, Goldenberg DL, Hauser W, Katz RS, et al. Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR Preliminary Diagnostic Criteria for Fibromyalgia. J Rheumatol. 2011;38:1113\u201322.","journal-title":"J Rheumatol"},{"key":"1244_CR10","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.sjbs.2020.01.020","volume":"27","author":"RA Alharbi","year":"2020","unstructured":"Alharbi RA. Proteomics approach and techniques in identification of reliable biomarkers for diseases. Saudi J Biol Sci. 2020;27:968\u201374.","journal-title":"Saudi J Biol Sci"},{"key":"1244_CR11","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","volume":"338","author":"KA Sluka","year":"2016","unstructured":"Sluka KA, Clauw DJ. Neurobiology of fibromyalgia and chronic widespread pain. Neuroscience. 2016;338:114\u201329.","journal-title":"Neuroscience"},{"key":"1244_CR12","doi-asserted-by":"publisher","first-page":"R185","DOI":"10.1186\/ar3513","volume":"13","author":"C Lerma","year":"2011","unstructured":"Lerma C, Martinez A, Ruiz N, Vargas A, Infante O, Martinez-Lavin M. Nocturnal heart rate variability parameters as potential fibromyalgia biomarker: correlation with symptoms severity. Arthritis Res Ther. 2011;13:R185.","journal-title":"Arthritis Res Ther"},{"key":"1244_CR13","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1002\/art.30185","volume":"63","author":"BI Nicholl","year":"2011","unstructured":"Nicholl BI, Holliday KL, Macfarlane GJ, Thomson W, Davies KA, O\u2019Neill TW, et al. Association of HTR2A polymorphisms with chronic widespread pain and the extent of musculoskeletal pain: results from two population-based cohorts. Arthritis Rheum. 2011;63:810\u20138.","journal-title":"Arthritis Rheum"},{"key":"1244_CR14","volume":"12","author":"MM Peck","year":"2020","unstructured":"Peck MM, Maram R, Mohamed A, Ochoa Crespo D, Kaur G, Ashraf I, et al. The influence of pro-inflammatory cytokines and genetic variants in the development of fibromyalgia: a traditional review. Cureus. 2020;12: e10276.","journal-title":"Cureus"},{"key":"1244_CR15","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.jpsychores.2011.09.010","volume":"72","author":"R Riva","year":"2012","unstructured":"Riva R, Mork PJ, Westgaard RH, Okkenhaug Johansen T, Lundberg U. Catecholamines and heart rate in female fibromyalgia patients. J Psychosom Res. 2012;72:51\u20137.","journal-title":"J Psychosom Res"},{"key":"1244_CR16","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1046\/j.1365-2249.2003.02149.x","volume":"132","author":"MR Amel Kashipaz","year":"2003","unstructured":"Amel Kashipaz MR, Swinden D, Todd I, Powell RJ. Normal production of inflammatory cytokines in chronic fatigue and fibromyalgia syndromes determined by intracellular cytokine staining in short-term cultured blood mononuclear cells. Clin Exp Immunol. 2003;132:360\u20135.","journal-title":"Clin Exp Immunol"},{"key":"1244_CR17","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1002\/art.37842","volume":"65","author":"LM Arnold","year":"2013","unstructured":"Arnold LM, Fan J, Russell IJ, Yunus MB, Khan MA, Kushner I, et al. The fibromyalgia family study: a genome-wide linkage scan study. Arthritis Rheum. 2013;65:1122\u20138.","journal-title":"Arthritis Rheum"},{"key":"1244_CR18","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1001\/jamaophthalmol.2015.4105","volume":"134","author":"S Patel","year":"2016","unstructured":"Patel S, Ling J, Kim SJ, Schey KL, Rose K, Kuchtey RW. Proteomic analysis of macular fluid associated with advanced glaucomatous excavation. JAMA Ophthalmol. 2016;134:108\u201310.","journal-title":"JAMA Ophthalmol"},{"key":"1244_CR19","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1093\/chromsci\/bmw167","volume":"55","author":"B Aslam","year":"2017","unstructured":"Aslam B, Basit M, Nisar MA, Khurshid M, Rasool MH. Proteomics: technologies and their applications. J Chromatogr Sci. 2017;55:182\u201396.","journal-title":"J Chromatogr Sci"},{"key":"1244_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372: n71.","journal-title":"BMJ"},{"key":"1244_CR21","doi-asserted-by":"publisher","first-page":"I6890","DOI":"10.1136\/bmj.l6890","volume":"368","author":"M Campbell","year":"2020","unstructured":"Campbell M, McKenzie JE, Sowden A, Katikireddi SV, Brennan SE, Ellis S, et al. Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline. BMJ. 2020;368:I6890.","journal-title":"BMJ"},{"key":"1244_CR22","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","volume":"5","author":"M Ouzzani","year":"2016","unstructured":"Ouzzani M, Hammady H, Fedorowicz Z, Elmagarmid A. Rayyan\u2014a web and mobile app for systematic reviews. Syst Rev. 2016;5:210.","journal-title":"Syst Rev"},{"key":"1244_CR23","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1136\/emj.18.3.205","volume":"18","author":"A-M Kelly","year":"2001","unstructured":"Kelly A-M. The minimum clinically significant difference in visual analogue scale pain score does not differ with severity of pain. Emerg Med J. 2001;18:205\u20137.","journal-title":"Emerg Med J"},{"key":"1244_CR24","unstructured":"Wells GA, Shea Beverley, O\u2019Connell Dianne, Peterson Joan, Welch Vivian, Losos Michael, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ontario, Canada; 2000."},{"key":"1244_CR25","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214671","volume":"14","author":"TPH Nguyen","year":"2019","unstructured":"Nguyen TPH, Patrick CJ, Parry LJ, Familari M. Using proteomics to advance the search for potential biomarkers for preeclampsia: a systematic review and meta-analysis. PLoS ONE. 2019;14: e0214671.","journal-title":"PLoS ONE"},{"key":"1244_CR26","doi-asserted-by":"publisher","first-page":"2071","DOI":"10.1074\/mcp.E800011-MCP200","volume":"7","author":"JE Celis","year":"2008","unstructured":"Celis JE, Carr SA, Bradshaw RA. New guidelines for clinical proteomics manuscripts. Mol Cell Proteomics. 2008;7:2071\u20132.","journal-title":"Mol Cell Proteomics"},{"key":"1244_CR27","doi-asserted-by":"publisher","first-page":"412","DOI":"10.5535\/arm.2011.35.3.412","volume":"35","author":"G Park","year":"2011","unstructured":"Park G, Kim CW, Park SB, Kim MJ, Jang SH. Reliability and usefulness of the pressure pain threshold measurement in patients with myofascial pain. Ann Rehabil Med. 2011;35:412\u20137.","journal-title":"Ann Rehabil Med"},{"key":"1244_CR28","first-page":"603","volume":"29","author":"G Lundberg","year":"2002","unstructured":"Lundberg G, Gerdle B. Tender point scores and their relations to signs of mobility, symptoms, and disability in female home care personnel and the prevalence of fibromyalgia syndrome. J Rheumatol. 2002;29:603\u201313.","journal-title":"J Rheumatol"},{"key":"1244_CR29","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/1477-7525-1-79","volume":"1","author":"K Webster","year":"2003","unstructured":"Webster K, Cella D, Yost K. The F unctional A ssessment of C hronic I llness T herapy (FACIT) Measurement System: properties, applications, and interpretation. Health Qual Life Outcomes. 2003;1:79.","journal-title":"Health Qual Life Outcomes"},{"key":"1244_CR30","first-page":"728","volume":"18","author":"CS Burckhardt","year":"1991","unstructured":"Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728\u201333.","journal-title":"J Rheumatol"},{"issue":"Suppl 1","key":"1244_CR31","first-page":"S86","volume":"63","author":"DA Williams","year":"2011","unstructured":"Williams DA, Arnold LM. Measures of fibromyalgia: Fibromyalgia Impact Questionnaire (FIQ), Brief Pain Inventory (BPI), Multidimensional Fatigue Inventory (MFI-20), Medical Outcomes Study (MOS) Sleep Scale, and Multiple Ability Self-Report Questionnaire (MASQ). Arthritis Care Res (Hoboken). 2011;63(Suppl 1):S86\u201397.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1244_CR32","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","volume":"28","author":"DJ Buysse","year":"1989","unstructured":"Buysse DJ, Reynolds CF, Monk TH, Berman SR, Kupfer DJ. The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research. Psychiatry Res. 1989;28:193\u2013213.","journal-title":"Psychiatry Res"},{"key":"1244_CR33","doi-asserted-by":"publisher","first-page":"205031211667172","DOI":"10.1177\/2050312116671725","volume":"4","author":"L Lins","year":"2016","unstructured":"Lins L, Carvalho FM. SF-36 total score as a single measure of health-related quality of life: scoping review. SAGE Open Med. 2016;4:205031211667172.","journal-title":"SAGE Open Med"},{"key":"1244_CR34","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1016\/j.addbeh.2007.09.020","volume":"33","author":"J Lykke","year":"2008","unstructured":"Lykke J, Hesse M, Austin SF, Oestrich I. Validity of the BPRS, the BDI and the BAI in dual diagnosis patients. Addict Behav. 2008;33:292\u2013300.","journal-title":"Addict Behav"},{"key":"1244_CR35","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0272-7358(88)90050-5","volume":"8","author":"AT Beck","year":"1988","unstructured":"Beck AT, Steer RA, Carbin MG. Psychometric properties of the Beck Depression Inventory: twenty-five years of evaluation. Clin Psychol Rev. 1988;8:77\u2013100.","journal-title":"Clin Psychol Rev"},{"key":"1244_CR36","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0022-3999(01)00296-3","volume":"52","author":"I Bjelland","year":"2022","unstructured":"Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the Hospital Anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2022;52:69\u201377.","journal-title":"J Psychosom Res"},{"key":"1244_CR37","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.874490","volume":"13","author":"S Fineschi","year":"2022","unstructured":"Fineschi S, Klar J, Gustafsson KA, Jonsson K, Karlsson B, Dahl N. Inflammation and interferon signatures in peripheral B-lymphocytes and sera of individuals with fibromyalgia. Front Immunol. 2022;13: 874490.","journal-title":"Front Immunol"},{"key":"1244_CR38","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.jprot.2018.04.012","volume":"190","author":"F Ciregia","year":"2019","unstructured":"Ciregia F, Giacomelli C, Giusti L, Boldrini C, Piga I, Pepe P, et al. Putative salivary biomarkers useful to differentiate patients with fibromyalgia. J Proteomics. 2019;190:44\u201354.","journal-title":"J Proteomics"},{"key":"1244_CR39","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1002\/prca.200900076","volume":"3","author":"L Bazzichi","year":"2009","unstructured":"Bazzichi L, Ciregia F, Giusti L, Baldini C, Giannaccini G, Giacomelli C, et al. Detection of potential markers of primary fibromyalgia syndrome in human saliva. Proteomics Clin Appl. 2009;3:1296\u2013304.","journal-title":"Proteomics Clin Appl"},{"key":"1244_CR40","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jprot.2018.07.009","volume":"186","author":"JA Ram\u00edrez-Tejero","year":"2018","unstructured":"Ram\u00edrez-Tejero JA, Mart\u00ednez-Lara E, Rus A, Camacho MV, Del Moral ML, Siles E. Insight into the biological pathways underlying fibromyalgia by a proteomic approach. J Proteomics. 2018;186:47\u201355.","journal-title":"J Proteomics"},{"key":"1244_CR41","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jprot.2018.04.014","volume":"190","author":"PE Khoonsari","year":"2019","unstructured":"Khoonsari PE, Musunri S, Herman S, Svensson CI, Tanum L, Gordh T, et al. Systematic analysis of the cerebrospinal fluid proteome of fibromyalgia patients. J Proteomics. 2019;190:35\u201343.","journal-title":"J Proteomics"},{"key":"1244_CR42","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.jprot.2018.05.012","volume":"190","author":"PE Khoonsari","year":"2019","unstructured":"Khoonsari PE, Ossipova E, Lengqvist J, Svensson CI, Kosek E, Kadetoff D, et al. The human CSF pain proteome. J Proteomics. 2019;190:67\u201376.","journal-title":"J Proteomics"},{"key":"1244_CR43","doi-asserted-by":"publisher","first-page":"e207","DOI":"10.1515\/cclm-2014-0086","volume":"52","author":"V Ruggiero","year":"2014","unstructured":"Ruggiero V, Era B, Cacace E, Molin L, Corda M, Fais A, et al. A preliminary study on serum proteomics in fibromyalgia syndrome. Clin Chem Lab Med. 2014;52:e207\u2013210.","journal-title":"Clin Chem Lab Med"},{"key":"1244_CR44","doi-asserted-by":"publisher","first-page":"12508","DOI":"10.1038\/s41598-020-69422-z","volume":"10","author":"K W\u00e5hl\u00e9n","year":"2020","unstructured":"W\u00e5hl\u00e9n K, Ernberg M, Kosek E, Mannerkorpi K, Gerdle B, Ghafouri B. Significant correlation between plasma proteome profile and pain intensity, sensitivity, and psychological distress in women with fibromyalgia. Sci Rep. 2020;10:12508.","journal-title":"Sci Rep"},{"key":"1244_CR45","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1002\/ejp.1871","volume":"26","author":"W Hsu","year":"2022","unstructured":"\u2022 Hsu W, Han D, Ku W, Chao Y, Chen C, Lin Y. Metabolomic and proteomic characterization of sng and pain phenotypes in fibromyalgia. Eur J Pain. 2022;26:445\u201362. The study identified potential biomarkers from FM patients that could discriminate sng and pain phenotypes in patients with FMS.","journal-title":"Eur J Pain"},{"key":"1244_CR46","doi-asserted-by":"publisher","first-page":"12347","DOI":"10.1038\/s41598-020-69271-w","volume":"10","author":"C-L Han","year":"2020","unstructured":"Han C-L, Sheng Y-C, Wang S-Y, Chen Y-H, Kang J-H. Serum proteome profiles revealed dysregulated proteins and mechanisms associated with fibromyalgia syndrome in women. Sci Rep. 2020;10:12347.","journal-title":"Sci Rep"},{"key":"1244_CR47","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/j.ebiom.2019.07.031","volume":"46","author":"M Clos-Garcia","year":"2019","unstructured":"Clos-Garcia M, Andr\u00e9s-Marin N, Fern\u00e1ndez-Eulate G, Abecia L, Lav\u00edn JL, van Liempd S, et al. Gut microbiome and serum metabolome analyses identify molecular biomarkers and altered glutamate metabolism in fibromyalgia. EBioMedicine. 2019;46:499\u2013511.","journal-title":"EBioMedicine"},{"key":"1244_CR48","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1067\/mem.2001.118863","volume":"38","author":"EJ Gallagher","year":"2001","unstructured":"Gallagher EJ, Liebman M, Bijur PE. Prospective validation of clinically important changes in pain severity measured on a visual analog scale. Ann Emerg Med. 2001;38:633\u20138.","journal-title":"Ann Emerg Med"},{"key":"1244_CR49","doi-asserted-by":"publisher","first-page":"S240","DOI":"10.1002\/acr.20543","volume":"63","author":"GA Hawker","year":"2011","unstructured":"Hawker GA, Mian S, Kendzerska T, French M. Measures of adult pain: Visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF. Arthritis Care Res (Hoboken). 2011;63:S240\u201352.","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"1244_CR50","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/j.ajem.2018.01.008","volume":"36","author":"O Karcioglu","year":"2018","unstructured":"Karcioglu O, Topacoglu H, Dikme O, Dikme O. A systematic review of the pain scales in adults: which to use? Am J Emerg Med. 2018;36:707\u201314.","journal-title":"Am J Emerg Med"},{"key":"1244_CR51","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/0887-6185(93)90002-3","volume":"7","author":"RA Steer","year":"1993","unstructured":"Steer RA, Ranieri WF, Beck AT, Clark DA. Further evidence for the validity of the beck anxiety inventory with psychiatric outpatients. J Anxiety Disord. 1993;7:195\u2013205.","journal-title":"J Anxiety Disord"},{"key":"1244_CR52","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1093\/bfgp\/3.4.382","volume":"3","author":"RJ Beynon","year":"2005","unstructured":"Beynon RJ. The dynamics of the proteome: strategies for measuring protein turnover on a proteome-wide scale. Brief Funct Genomic Proteomic. 2005;3:382\u201390.","journal-title":"Brief Funct Genomic Proteomic"},{"key":"1244_CR53","volume":"2009","author":"K Chandramouli","year":"2009","unstructured":"Chandramouli K, Qian P-Y. Proteomics: challenges, techniques and possibilities to overcome biological sample complexity. Hum Genomics Proteomics. 2009;2009: 239204.","journal-title":"Hum Genomics Proteomics"},{"key":"1244_CR54","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.molmed.2011.01.014","volume":"17","author":"A Perl","year":"2011","unstructured":"Perl A, Hanczko R, Telarico T, Oaks Z, Landas S. Oxidative stress, inflammation and carcinogenesis are controlled through the pentose phosphate pathway by transaldolase. Trends Mol Med. 2011;17:395\u2013403.","journal-title":"Trends Mol Med"},{"key":"1244_CR55","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.jneuroim.2009.11.014","volume":"219","author":"A Kimura","year":"2010","unstructured":"Kimura A, Sakurai T, Koumura A, Yamada M, Hayashi Y, Tanaka Y, et al. High prevalence of autoantibodies against phosphoglycerate mutase 1 in patients with autoimmune central nervous system diseases. J Neuroimmunol. 2010;219:105\u20138.","journal-title":"J Neuroimmunol"},{"key":"1244_CR56","doi-asserted-by":"publisher","first-page":"64","DOI":"10.3892\/mmr.2020.11702","volume":"23","author":"W Hu","year":"2021","unstructured":"Hu W, Lin C. S100a8 silencing attenuates inflammation, oxidative stress and apoptosis in BV2 cells induced by oxygen-glucose deprivation and reoxygenation by upregulating GAB1 expression. Mol Med Rep. 2021;23:64.","journal-title":"Mol Med Rep"},{"key":"1244_CR57","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1097\/MOL.0000000000000502","volume":"29","author":"B Ramms","year":"2018","unstructured":"Ramms B, Gordts PLSM. Apolipoprotein C-III in triglyceride-rich lipoprotein metabolism. Curr Opin Lipidol. 2018;29:171\u20139.","journal-title":"Curr Opin Lipidol"},{"key":"1244_CR58","doi-asserted-by":"publisher","first-page":"4646","DOI":"10.1073\/pnas.76.9.4646","volume":"76","author":"PS Roheim","year":"1979","unstructured":"Roheim PS, Carey M, Forte T, Vega GL. Apolipoproteins in human cerebrospinal fluid. Proc Natl Acad Sci USA. 1979;76:4646\u20139.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1244_CR59","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.694928","volume":"12","author":"H Wang","year":"2021","unstructured":"Wang H, Liu M. Complement C4, infections, and autoimmune diseases. Front Immunol. 2021;12: 694928.","journal-title":"Front Immunol"},{"key":"1244_CR60","first-page":"257","volume":"21","author":"P Min\u00e1rik","year":"2002","unstructured":"Min\u00e1rik P, Tom\u00e1skov\u00e1 N, Koll\u00e1rov\u00e1 M, Antal\u00edk M. Malate dehydrogenases\u2013structure and function. Gen Physiol Biophys. 2002;21:257\u201365.","journal-title":"Gen Physiol Biophys"},{"key":"1244_CR61","first-page":"953","volume":"22","author":"IJ Russell","year":"1995","unstructured":"Russell IJ, Michalek JE, Flechas JD, Abraham GE. Treatment of fibromyalgia syndrome with Super Malic: a randomized, double blind, placebo controlled, crossover pilot study. J Rheumatol. 1995;22:953\u20138.","journal-title":"J Rheumatol"},{"key":"1244_CR62","doi-asserted-by":"publisher","first-page":"2788","DOI":"10.1002\/art.11287","volume":"48","author":"S Ohshima","year":"2003","unstructured":"Ohshima S, Kuchen S, Seemayer CA, Kyburz D, Hirt A, Klinzing S, et al. Galectin 3 and its binding protein in rheumatoid arthritis. Arthritis Rheum. 2003;48:2788\u201395.","journal-title":"Arthritis Rheum"},{"key":"1244_CR63","doi-asserted-by":"publisher","first-page":"4141","DOI":"10.1210\/endo.142.9.8386","volume":"142","author":"E Lanoue","year":"2001","unstructured":"Lanoue E, Day R. Coexpression of proprotein convertase SPC3 and the neuroendocrine precursor proSAAS. Endocrinology. 2001;142:4141\u20139.","journal-title":"Endocrinology"},{"key":"1244_CR64","doi-asserted-by":"publisher","first-page":"32720","DOI":"10.1074\/jbc.M104064200","volume":"276","author":"A Basak","year":"2001","unstructured":"Basak A, Koch P, Dupelle M, Fricker LD, Devi LA, Chr\u00e9tien M, et al. Inhibitory specificity and potency of proSAAS-derived peptides toward proprotein convertase 1. J Biol Chem. 2001;276:32720\u20138.","journal-title":"J Biol Chem"},{"key":"1244_CR65","doi-asserted-by":"publisher","first-page":"6207","DOI":"10.1074\/jbc.M009067200","volume":"276","author":"N Mzhavia","year":"2001","unstructured":"Mzhavia N, Berman Y, Che FY, Fricker LD, Devi LA. ProSAAS processing in mouse brain and pituitary. J Biol Chem. 2001;276:6207\u201313.","journal-title":"J Biol Chem"},{"key":"1244_CR66","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11916-009-0058-1","volume":"13","author":"MM Valen\u00e7a","year":"2009","unstructured":"Valen\u00e7a MM, Medeiros FL, Martins HA, Massaud RM, Peres MFP. Neuroendocrine dysfunction in fibromyalgia and migraine. Curr Pain Headache Rep. 2009;13:358\u201364.","journal-title":"Curr Pain Headache Rep"},{"key":"1244_CR67","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.aca.2018.03.009","volume":"1037","author":"X Liu","year":"2018","unstructured":"Liu X, Hoene M, Wang X, Yin P, H\u00e4ring H-U, Xu G, et al. Serum or plasma, what is the difference? Investigations to facilitate the sample material selection decision making process for metabolomics studies and beyond. Anal Chim Acta. 2018;1037:293\u2013300.","journal-title":"Anal Chim Acta"},{"key":"1244_CR68","doi-asserted-by":"publisher","first-page":"1700088","DOI":"10.1002\/prca.201700088","volume":"12","author":"A Baralla","year":"2018","unstructured":"Baralla A, Fois AG, Sotgiu E, Zinellu E, Mangoni AA, Sotgia S, et al. Plasma proteomic signatures in early chronic obstructive pulmonary disease. Proteomics Clin Appl. 2018;12:1700088.","journal-title":"Proteomics Clin Appl"},{"key":"1244_CR69","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1089\/ars.2016.6793","volume":"26","author":"CBF Andersen","year":"2017","unstructured":"Andersen CBF, St\u00f8dkilde K, S\u00e6derup KL, Kuhlee A, Raunser S, Graversen JH, et al. Haptoglobin. Antioxid Redox Signal. 2017;26:814\u201331.","journal-title":"Antioxid Redox Signal"},{"key":"1244_CR70","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/S0049-3848(02)00042-7","volume":"105","author":"G Cvirn","year":"2002","unstructured":"Cvirn G, Gallistl S, Koestenberger M, Kutschera J, Leschnik B, Muntean W. Alpha 2-macroglobulin enhances prothrombin activation and thrombin potential by inhibiting the anticoagulant protein C\/protein S system in cord and adult plasma. Thromb Res. 2002;105:433\u20139.","journal-title":"Thromb Res"},{"key":"1244_CR71","first-page":"225","volume":"25","author":"L Bazzichi","year":"2007","unstructured":"Bazzichi L, Rossi A, Massimetti G, Giannaccini G, Giuliano T, De Feo F, et al. Cytokine patterns in fibromyalgia and their correlation with clinical manifestations. Clin Exp Rheumatol. 2007;25:225\u201330.","journal-title":"Clin Exp Rheumatol"},{"key":"1244_CR72","doi-asserted-by":"crossref","unstructured":"Allen A, Gau D, Roy P. The role of profilin-1 in cardiovascular diseases. J Cell Sci. 2021;134:jcs249060.","DOI":"10.1242\/jcs.249060"},{"key":"1244_CR73","doi-asserted-by":"publisher","first-page":"1439","DOI":"10.1007\/s11033-021-06210-6","volume":"48","author":"C-J Lee","year":"2021","unstructured":"Lee C-J, Yoon M-J, Kim DH, Kim TU, Kang Y-J. Profilin-1; a novel regulator of DNA damage response and repair machinery in keratinocytes. Mol Biol Rep. 2021;48:1439\u201352.","journal-title":"Mol Biol Rep"},{"key":"1244_CR74","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1111\/j.1574-695X.1999.tb01390.x","volume":"26","author":"CJ de Haas","year":"1999","unstructured":"de Haas CJ. New insights into the role of serum amyloid P component, a novel lipopolysaccharide-binding protein. FEMS Immunol Med Microbiol. 1999;26:197\u2013202.","journal-title":"FEMS Immunol Med Microbiol"},{"key":"1244_CR75","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1189\/jlb.1MR0114-068R","volume":"96","author":"N Cox","year":"2014","unstructured":"Cox N, Pilling D, Gomer RH. Serum amyloid P: a systemic regulator of the innate immune response. J Leukoc Biol. 2014;96:739\u201343.","journal-title":"J Leukoc Biol"},{"key":"1244_CR76","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1159\/000178756","volume":"26","author":"NA Verwey","year":"2008","unstructured":"Verwey NA, Schuitemaker A, van der Flier WM, Mulder SD, Mulder C, Hack CE, et al. Serum amyloid P component as a biomarker in mild cognitive impairment and Alzheimer\u2019s disease. Dement Geriatr Cogn Disord. 2008;26:522\u20137.","journal-title":"Dement Geriatr Cogn Disord"},{"key":"1244_CR77","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1002\/rth2.12291","volume":"4","author":"JA Fern\u00e1ndez","year":"2020","unstructured":"Fern\u00e1ndez JA, Deguchi H, Elias DJ, Griffin JH. Serum amyloid A4 is a procoagulant apolipoprotein that it is elevated in venous thrombosis patients. Res Pract Thromb Haemost. 2020;4:217\u201323.","journal-title":"Res Pract Thromb Haemost"},{"key":"1244_CR78","doi-asserted-by":"publisher","first-page":"4062","DOI":"10.3390\/ijms22084062","volume":"22","author":"A Kale","year":"2021","unstructured":"Kale A, Rogers NM, Ghimire K. Thrombospondin-1 CD47 signalling: from mechanisms to medicine. Int J Mol Sci. 2021;22:4062.","journal-title":"Int J Mol Sci"},{"key":"1244_CR79","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1016\/j.biocel.2004.01.025","volume":"36","author":"ML Iruela-Arispe","year":"2004","unstructured":"Iruela-Arispe ML, Luque A, Lee N. Thrombospondin modules and angiogenesis. Int J Biochem Cell Biol. 2004;36:1070\u20138.","journal-title":"Int J Biochem Cell Biol"},{"key":"1244_CR80","doi-asserted-by":"publisher","first-page":"193","DOI":"10.18773\/austprescr.2016.069","volume":"39","author":"J Baird-Gunning","year":"2016","unstructured":"Baird-Gunning J, Bromley J. Correcting iron deficiency. Aust Prescr. 2016;39:193\u20136.","journal-title":"Correcting iron deficiency Aust Prescr"},{"key":"1244_CR81","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/ejcn.2009.149","volume":"64","author":"O Ortancil","year":"2010","unstructured":"Ortancil O, Sanli A, Eryuksel R, Basaran A, Ankarali H. Association between serum ferritin level and fibromyalgia syndrome. Eur J Clin Nutr. 2010;64:308\u201312.","journal-title":"Eur J Clin Nutr"},{"key":"1244_CR82","doi-asserted-by":"publisher","first-page":"1698","DOI":"10.1212\/WNL.54.8.1698","volume":"54","author":"CJ Earley","year":"2000","unstructured":"Earley CJ, Connor JR, Beard JL, Malecki EA, Epstein DK, Allen RP. Abnormalities in CSF concentrations of ferritin and transferrin in restless legs syndrome. Neurology. 2000;54:1698\u2013700.","journal-title":"Neurology"},{"key":"1244_CR83","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1111\/j.1365-2869.2004.00403.x","volume":"14","author":"S Mizuno","year":"2005","unstructured":"Mizuno S, Mihara T, Miyaoka T, Inagaki T, Horiguchi J. CSF iron, ferritin and transferrin levels in restless legs syndrome. J Sleep Res. 2005;14:43\u20137.","journal-title":"J Sleep Res"},{"key":"1244_CR84","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10067-011-1888-x","volume":"31","author":"R Mader","year":"2012","unstructured":"Mader R, Koton Y, Buskila D, Herer P, Elias M. Serum iron and iron stores in non-anemic patients with fibromyalgia. Clin Rheumatol. 2012;31:595\u20139.","journal-title":"Clin Rheumatol"},{"key":"1244_CR85","doi-asserted-by":"publisher","first-page":"10496","DOI":"10.1038\/s41598-021-89842-9","volume":"11","author":"WC Yao","year":"2021","unstructured":"Yao WC, Chen HJ, Leong KH, Chang KL, Wang YTT, Wu LC, et al. The risk of fibromyalgia in patients with iron deficiency anemia: a nationwide population-based cohort study. Sci Rep. 2021;11:10496.","journal-title":"Sci Rep"},{"key":"1244_CR86","first-page":"10375","volume":"27","author":"H Hamarat","year":"2023","unstructured":"Hamarat H, G\u00fcrc\u00fc S, K\u0131van\u00e7 BK, Aydemir AE. Ferric carboxymaltose therapy reduces pain and improves the quality of life in female patients with fibromyalgia. Eur Rev Med Pharmacol Sci. 2023;27:10375\u201380.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1244_CR87","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s40744-017-0088-9","volume":"5","author":"CS Boomershine","year":"2018","unstructured":"Boomershine CS, Koch TA, Morris D. A blinded, randomized, placebo-controlled study to investigate the efficacy and safety of ferric carboxymaltose in iron-deficient patients with fibromyalgia. Rheumatol Ther. 2018;5:271\u201381.","journal-title":"Rheumatol Ther"},{"key":"1244_CR88","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1177\/1099800418824716","volume":"21","author":"F Molina","year":"2019","unstructured":"Molina F, del Moral ML, La Rubia M, Blanco S, Carmona R, Rus A. Are patients with fibromyalgia in a prothrombotic state? Biol Res Nurs. 2019;21:224\u201330.","journal-title":"Biol Res Nurs"},{"key":"1244_CR89","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1038\/ni.1923","volume":"11","author":"D Ricklin","year":"2010","unstructured":"Ricklin D, Hajishengallis G, Yang K, Lambris JD. Complement: a key system for immune surveillance and homeostasis. Nat Immunol. 2010;11:785\u201397.","journal-title":"Nat Immunol"},{"key":"1244_CR90","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00281-011-0280-x","volume":"34","author":"K Oikonomopoulou","year":"2012","unstructured":"Oikonomopoulou K, Ricklin D, Ward PA, Lambris JD. Interactions between coagulation and complement\u2013their role in inflammation. Semin Immunopathol. 2012;34:151\u201365.","journal-title":"Semin Immunopathol"},{"key":"1244_CR91","doi-asserted-by":"publisher","first-page":"1403","DOI":"10.1007\/s10067-010-1474-7","volume":"29","author":"I Blanco","year":"2010","unstructured":"Blanco I, B\u00e9ritze N, Arg\u00fcelles M, C\u00e1rcaba V, Fern\u00e1ndez F, Janciauskiene S, et al. Abnormal overexpression of mastocytes in skin biopsies of fibromyalgia patients. Clin Rheumatol. 2010;29:1403\u201312.","journal-title":"Clin Rheumatol"},{"key":"1244_CR92","doi-asserted-by":"publisher","first-page":"308","DOI":"10.3109\/03009749709105321","volume":"26","author":"S Enestr\u00f6m","year":"1997","unstructured":"Enestr\u00f6m S, Bengtsson A, Fr\u00f6din T. Dermal IgG deposits and increase of mast cells in patients with fibromyalgia\u2013relevant findings or epiphenomena? Scand J Rheumatol. 1997;26:308\u201313.","journal-title":"Scand J Rheumatol"},{"key":"1244_CR93","doi-asserted-by":"publisher","first-page":"2776","DOI":"10.1038\/sj.npp.1301200","volume":"31","author":"SA McLean","year":"2006","unstructured":"McLean SA, Williams DA, Stein PK, Harris RE, Lyden AK, Whalen G, et al. Cerebrospinal fluid corticotropin-releasing factor concentration is associated with pain but not fatigue symptoms in patients with fibromyalgia. Neuropsychopharmacology Neuropsychopharmacology. 2006;31:2776\u201382.","journal-title":"Neuropsychopharmacology Neuropsychopharmacology"},{"key":"1244_CR94","doi-asserted-by":"publisher","first-page":"1593","DOI":"10.1002\/art.1780371106","volume":"37","author":"IJ Russell","year":"1994","unstructured":"Russell IJ, Orr MD, Littman B, Vipraio GA, Alboukrek D, Michalek JE, et al. Elevated cerebrospinal fluid levels of substance P in patients with the fibromyalgia syndrome. Arthritis Rheum. 1994;37:1593\u2013601.","journal-title":"Arthritis Rheum"},{"key":"1244_CR95","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1146\/annurev.immunol.15.1.675","volume":"15","author":"M Baggiolini","year":"1997","unstructured":"Baggiolini M, Dewald B, Moser B. Human chemokines: an update. Annu Rev Immunol. 1997;15:675\u2013705.","journal-title":"Annu Rev Immunol"},{"key":"1244_CR96","doi-asserted-by":"publisher","first-page":"156","DOI":"10.3390\/diagnostics11020156","volume":"11","author":"KV Hackshaw","year":"2021","unstructured":"Hackshaw KV. The search for biomarkers in fibromyalgia. Diagnostics. 2021;11:156.","journal-title":"Diagnostics"},{"key":"1244_CR97","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1111\/j.1526-4637.2011.01179.x","volume":"12","author":"DC Ang","year":"2011","unstructured":"Ang DC, Moore MN, Hilligoss J, Tabbey R. MCP-1 and IL-8 as pain biomarkers in fibromyalgia: a pilot study. Pain Med. 2011;12:1154\u201361.","journal-title":"Pain Med"},{"key":"1244_CR98","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3389\/fncel.2015.00354","volume":"9","author":"S Bardehle","year":"2015","unstructured":"Bardehle S, Rafalski VA, Akassoglou K. Breaking boundaries-coagulation and fibrinolysis at the neurovascular interface. Front Cell Neurosci. 2015;9:354.","journal-title":"Front Cell Neurosci"},{"key":"1244_CR99","doi-asserted-by":"publisher","first-page":"1076","DOI":"10.1038\/nature06559","volume":"451","author":"MH Han","year":"2008","unstructured":"Han MH, Hwang S-I, Roy DB, Lundgren DH, Price JV, Ousman SS, et al. Proteomic analysis of active multiple sclerosis lesions reveals therapeutic targets. Nature. 2008;451:1076\u201381.","journal-title":"Nature"},{"key":"1244_CR100","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1016\/j.pain.2013.06.001","volume":"154","author":"AL Oaklander","year":"2013","unstructured":"Oaklander AL, Herzog ZD, Downs HM, Klein MM. Objective evidence that small-fiber polyneuropathy underlies some illnesses currently labeled as fibromyalgia. Pain. 2013;154:2310\u20136.","journal-title":"Pain"},{"key":"1244_CR101","doi-asserted-by":"publisher","first-page":"305","DOI":"10.4172\/2329-6895.1000305","volume":"4","author":"TD Levine","year":"2016","unstructured":"Levine TD, Saperstein DS, Levine A, Hackshaw K, Lawson V. Small fiber neuropathy in patients meeting diagnostic criteria for fibromyalgia. J Neurol Disord. 2016;4:305.","journal-title":"J Neurol Disord"},{"key":"1244_CR102","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1002\/mus.26131","volume":"58","author":"VH Lawson","year":"2018","unstructured":"Lawson VH, Grewal J, Hackshaw KV, Mongiovi PC, Stino AM. Fibromyalgia syndrome and small fiber, early or mild sensory polyneuropathy. Muscle Nerve. 2018;58:625\u201330.","journal-title":"Muscle Nerve"},{"key":"1244_CR103","doi-asserted-by":"publisher","first-page":"918","DOI":"10.3390\/nu12040918","volume":"12","author":"A Rus","year":"2020","unstructured":"Rus A, Molina F, Mart\u00ednez-Ram\u00edrez MJ, Aguilar-Ferr\u00e1ndiz ME, Carmona R, Del MML. Effects of olive oil consumption on cardiovascular risk factors in patients with fibromyalgia. Nutrients. 2020;12:918.","journal-title":"Nutrients"},{"key":"1244_CR104","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0100745","volume":"9","author":"E Bertaggia","year":"2014","unstructured":"Bertaggia E, Scabia G, Dalise S, Lo Verso F, Santini F, Vitti P, et al. Haptoglobin is required to prevent oxidative stress and muscle atrophy. PLoS ONE. 2014;9: e100745.","journal-title":"PLoS ONE"},{"key":"1244_CR105","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/0006-3223(93)90042-C","volume":"34","author":"M Maes","year":"1993","unstructured":"Maes M, Scharp\u00e9 S, Meltzer HY, Cosyns P. Relationships between increased haptoglobin plasma levels and activation of cell-mediated immunity in depression. Biol Psychiatry. 1993;34:690\u2013701.","journal-title":"Biol Psychiatry"},{"key":"1244_CR106","doi-asserted-by":"publisher","first-page":"1111559","DOI":"10.3389\/fpain.2023.1111559","volume":"4","author":"TJ Coderre","year":"2023","unstructured":"Coderre TJ. Contribution of microvascular dysfunction to chronic pain. Front Pain Res. 2023;4:1111559.","journal-title":"Front Pain Res"},{"key":"1244_CR107","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1007\/s00296-003-0427-8","volume":"25","author":"S Bagis","year":"2005","unstructured":"Bagis S, Tamer L, Sahin G, Bilgin R, Guler H, Ercan B, et al. Free radicals and antioxidants in primary fibromyalgia: an oxidative stress disorder? Rheumatol Int. 2005;25:188\u201390.","journal-title":"Rheumatol Int"},{"key":"1244_CR108","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1007\/s00296-005-0079-y","volume":"26","author":"S Ozgocmen","year":"2006","unstructured":"Ozgocmen S, Ozyurt H, Sogut S, Akyol O, Ardicoglu O, Yildizhan H. Antioxidant status, lipid peroxidation and nitric oxide in fibromyalgia: etiologic and therapeutic concerns. Rheumatol Int. 2006;26:598\u2013603.","journal-title":"Rheumatol Int"},{"key":"1244_CR109","doi-asserted-by":"publisher","first-page":"1582432","DOI":"10.1155\/2022\/1582432","volume":"2022","author":"C Assavarittirong","year":"2022","unstructured":"Assavarittirong C, Samborski W, Grygiel-G\u00f3rniak B. Oxidative stress in fibromyalgia: from pathology to treatment. Oxid Med Cell Longev. 2022;2022:1582432.","journal-title":"Oxid Med Cell Longev"},{"key":"1244_CR110","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1007\/s00296-008-0738-x","volume":"29","author":"OF Sendur","year":"2009","unstructured":"Sendur OF, Turan Y, Tastaban E, Yenisey C, Serter M. Serum antioxidants and nitric oxide levels in fibromyalgia: a controlled study. Rheumatol Int. 2009;29:629\u201333.","journal-title":"Rheumatol Int"},{"key":"1244_CR111","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.3390\/jcm11092462","volume":"11","author":"A Fern\u00e1ndez-Araque","year":"2022","unstructured":"Fern\u00e1ndez-Araque A, Verde Z, Torres-Ortega C, Sainz-Gil M, Velasco-Gonzalez V, Gonz\u00e1lez-Bernal JJ, et al. Effects of antioxidants on pain perception in patients with fibromyalgia\u2014a systematic review. J Clin Med. 2022;11:2462.","journal-title":"J Clin Med"},{"key":"1244_CR112","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-023-46980-6","volume":"13","author":"NS Elkholy","year":"2023","unstructured":"Elkholy NS, Mohammed HS, Shafaa MW. Assessment of the therapeutic potential of lutein and beta-carotene nanodispersions in a rat model of fibromyalgia. Sci Rep. 2023;13:1\u201318.","journal-title":"Sci Rep"},{"key":"1244_CR113","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1016\/j.biocel.2009.02.001","volume":"41","author":"AK Samland","year":"2009","unstructured":"Samland AK, Sprenger GA. Transaldolase: from biochemistry to human disease. Int J Biochem Cell Biol. 2009;41:1482\u201394.","journal-title":"Int J Biochem Cell Biol"},{"key":"1244_CR114","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1189\/jlb.69.6.986","volume":"69","author":"Z Yang","year":"2001","unstructured":"Yang Z, Tao T, Raftery MJ, Youssef P, Di Girolamo N, Geczy CL. Proinflammatory properties of the human S100 protein S100A12. J Leukoc Biol. 2001;69:986\u201394.","journal-title":"J Leukoc Biol"},{"key":"1244_CR115","doi-asserted-by":"publisher","first-page":"165","DOI":"10.4081\/reumatismo.2011.165","volume":"63","author":"C Giacomelli","year":"2011","unstructured":"Giacomelli C, Bazzichi L, Giusti L, Ciregia F, Baldini C, Da Valle Y, et al. MALDI-TOF and SELDI-TOF analysis: \u201ctandem\u201d techniques to identify potential biomarker in fibromyalgia. Reumatismo. 2011;63:165\u201370.","journal-title":"Reumatismo"},{"key":"1244_CR116","doi-asserted-by":"publisher","first-page":"2393","DOI":"10.1002\/fsn3.3251","volume":"11","author":"SM Derakhshandeh-Rishehri","year":"2023","unstructured":"Derakhshandeh-Rishehri SM, Kazemi A, Shim SR, Lotfi M, Mohabati S, Nouri M, et al. Effect of olive oil phenols on oxidative stress biomarkers: a systematic review and dose\u2013response meta-analysis of randomized clinical trials. Food Sci Nutr. 2023;11:2393\u2013402.","journal-title":"Food Sci Nutr"},{"key":"1244_CR117","doi-asserted-by":"publisher","first-page":"2772","DOI":"10.1080\/10408398.2018.1470491","volume":"59","author":"ES George","year":"2019","unstructured":"George ES, Marshall S, Mayr HL, Trakman GL, Tatucu-Babet OA, Lassemillante ACM, et al. The effect of high-polyphenol extra virgin olive oil on cardiovascular risk factors: a systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2019;59:2772\u201395.","journal-title":"Crit Rev Food Sci Nutr"},{"key":"1244_CR118","doi-asserted-by":"publisher","first-page":"2386","DOI":"10.3390\/nu12082386","volume":"12","author":"JA Ram\u00edrez-Tejero","year":"2020","unstructured":"Ram\u00edrez-Tejero JA, Mart\u00ednez-Lara E, Peinado M\u00c1, Del MML, Siles E. Hydroxytyrosol as a promising ally in the treatment of fibromyalgia. Nutrients. 2020;12:2386.","journal-title":"Nutrients"},{"key":"1244_CR119","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1177\/1099800416659370","volume":"19","author":"A Rus","year":"2017","unstructured":"Rus A, Molina F, Ramos MM, Mart\u00ednez-Ram\u00edrez MJ, del Moral ML. Extra virgin olive oil improves oxidative stress, functional capacity, and health-related psychological status in patients with fibromyalgia: a preliminary study. Biol Res Nurs. 2017;19:106\u201315.","journal-title":"Biol Res Nurs"},{"key":"1244_CR120","doi-asserted-by":"publisher","first-page":"174480691772455","DOI":"10.1177\/1744806917724559","volume":"13","author":"SK Totsch","year":"2017","unstructured":"Totsch SK, Sorge RE. Immune system involvement in specific pain conditions. Mol Pain. 2017;13:1744806917724559.","journal-title":"Mol Pain"},{"issue":"Suppl 1","key":"1244_CR121","first-page":"68","volume":"35","author":"JC Barton","year":"2017","unstructured":"Barton JC, Bertoli LF, Barton JC, Acton RT. Fibromyalgia in 300 adult index patients with primary immunodeficiency. Clin Exp Rheumatol. 2017;35(Suppl 1):68\u201373.","journal-title":"Clin Exp Rheumatol"},{"issue":"6","key":"1244_CR122","first-page":"1076","volume":"40","author":"XJ Caro","year":"2022","unstructured":"Caro XJ, Winter EF. Unexpectedly high prevalence of primary immune deficiency in fibromyalgia: serologic features and clinical correlates. Clin Exp Rheumatol. 2022;40(6):1076\u201383.","journal-title":"Clin Exp Rheumatol"},{"key":"1244_CR123","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.clicom.2022.02.003","volume":"2","author":"S Bj\u00f6rkander","year":"2022","unstructured":"\u2022 Bj\u00f6rkander S, Ernberg M, Bileviciute-Ljungar I. Reduced immune system responsiveness in fibromyalgia - a pilot study. Clin Immunol Commun. 2022;2:46\u201353. This pilot study shows evidence that the presence of immune aberrations in FMS is at least partially responsible for the associated pain sensation.","journal-title":"Clin Immunol Commun"},{"key":"1244_CR124","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.jneuroim.2010.11.003","volume":"233","author":"T Sakurai","year":"2011","unstructured":"Sakurai T, Kimura A, Yamada M, Koumura A, Hayashi Y, Tanaka Y, et al. Identification of antibodies as biological markers in serum from multiple sclerosis patients by immunoproteomic approach. J Neuroimmunol. 2011;233:175\u201380.","journal-title":"J Neuroimmunol"},{"key":"1244_CR125","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1177\/0333102417742366","volume":"38","author":"JH Nam","year":"2018","unstructured":"Nam JH, Lee HS, Kim J, Kim J, Chu MK. Salivary glutamate is elevated in individuals with chronic migraine. Cephalalgia. 2018;38:1485\u201392.","journal-title":"Cephalalgia"},{"key":"1244_CR126","doi-asserted-by":"publisher","first-page":"3695","DOI":"10.2147\/JPR.S311974","volume":"14","author":"JM Hagedorn","year":"2021","unstructured":"Hagedorn JM, Gunn J, Budwany R, D\u2019souza RS, Chakravarthy K, Deer TR. How well do current laboratory biomarkers inform clinical decision-making in chronic pain management? J Pain Res. 2021;14:3695\u2013710.","journal-title":"J Pain Res"},{"key":"1244_CR127","doi-asserted-by":"publisher","first-page":"2844","DOI":"10.1002\/art.24772","volume":"60","author":"NF Watson","year":"2009","unstructured":"Watson NF, Buchwald D, Goldberg J, Noonan C, Ellenbogen RG. Neurological signs and symptoms in fibromyalgia. Arthritis Rheum. 2009;60:2844.","journal-title":"Arthritis Rheum"},{"key":"1244_CR128","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijms22031100","volume":"22","author":"E Paszek","year":"2021","unstructured":"Paszek E, Zajdel W, Rajs T, \u017bmudka K, Legutko J, Kleczy\u0144ski P. Profilin 1 and mitochondria\u2014partners in the pathogenesis of coronary artery disease? Int J Mol Sci. 2021;22:1\u201316.","journal-title":"Int J Mol Sci"},{"key":"1244_CR129","first-page":"808","volume":"11","author":"UP Kalyan-Raman","year":"1984","unstructured":"Kalyan-Raman UP, Kalyan-Raman K, Yunus MB, Masi AT. Muscle pathology in primary fibromyalgia syndrome: a light microscopic, histochemical and ultrastructural study. J Rheumatol. 1984;11:808\u201313.","journal-title":"J Rheumatol"},{"key":"1244_CR130","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1093\/rheumatology\/32.6.479","volume":"32","author":"AM Drewes","year":"1993","unstructured":"Drewes AM, Andreasen A, Schr\u00f8der HD, H\u00f8gsaa B, Jennum P. Pathology of skeletal muscle in fibromyalgia: a histo-immuno-chemical and ultrastructural study. Br J Rheumatol. 1993;32:479\u201383.","journal-title":"Br J Rheumatol"},{"key":"1244_CR131","first-page":"1328","volume":"21","author":"W Grassi","year":"1994","unstructured":"Grassi W, Core P, Carlino G, Salaffi F, Cervini C. Capillary permeability in fibromyalgia. J Rheumatol. 1994;21:1328\u201331.","journal-title":"J Rheumatol"},{"key":"1244_CR132","doi-asserted-by":"publisher","first-page":"596","DOI":"10.4070\/kcj.2011.41.10.596","volume":"41","author":"JH Lee","year":"2011","unstructured":"Lee JH, Cho KI, Kim SM, Lee HG, Kim TI. Arterial stiffness in female patients with fibromyalgia and its relationship to chronic emotional and physical stress. Korean Circ J. 2011;41:596\u2013602.","journal-title":"Korean Circ J"},{"key":"1244_CR133","doi-asserted-by":"publisher","first-page":"1786","DOI":"10.3390\/biomedicines9121786","volume":"9","author":"Y Kim","year":"2021","unstructured":"Kim Y, Kim G-T, Kang J. Carotid arterial stiffness and cardiometabolic profiles in women with fibromyalgia. Biomedicines. 2021;9:1786.","journal-title":"Biomedicines"},{"key":"1244_CR134","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1007\/s10067-005-0004-5","volume":"25","author":"G Gurer","year":"2006","unstructured":"Gurer G, Sendur OF, Ay C. Serum lipid profile in fibromyalgia women. Clin Rheumatol. 2006;25:300\u20133.","journal-title":"Clin Rheumatol"},{"key":"1244_CR135","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.803244","volume":"12","author":"J Vandooren","year":"2021","unstructured":"Vandooren J, Itoh Y. Alpha-2-macroglobulin in inflammation, immunity and infections. Front Immunol. 2021;12: 803244.","journal-title":"Front Immunol"},{"key":"1244_CR136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2377-5-22","volume":"5","author":"JN Baraniuk","year":"2005","unstructured":"Baraniuk JN, Casado B, Maibach H, Clauw DJ, Pannell LK, Hess S. A chronic fatigue syndrome - related proteome in human cerebrospinal fluid. BMC Neurol. 2005;5:1\u201319.","journal-title":"BMC Neurol"},{"key":"1244_CR137","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.bbadis.2004.06.010","volume":"1690","author":"PEH Jensen","year":"2004","unstructured":"Jensen PEH, Humle J\u00f8rgensen S, Datta P, S\u00f8rensen PS. Significantly increased fractions of transformed to total alpha2-macroglobulin concentrations in plasma from patients with multiple sclerosis. Biochim Biophys Acta. 2004;1690:203\u20137.","journal-title":"Biochim Biophys Acta"},{"key":"1244_CR138","doi-asserted-by":"publisher","first-page":"779","DOI":"10.2217\/pmt-2022-0006","volume":"12","author":"JC De Castro","year":"2022","unstructured":"\u2022 De Castro JC, Wang D, Chien GCC. Regenerative medicine for neuropathic pain: physiology, ultrasound and therapies with a focus on alpha-2-macroglobulin. Pain Manag. 2022;12:779\u201393. This review indicates that A2M can be efficacious in reducing neuropathic pain due to its conformational change during activation and specificity of action on various cytokines.","journal-title":"Pain Manag"},{"key":"1244_CR139","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2217\/pmt-2023-0005","volume":"13","author":"JC de Castro","year":"2023","unstructured":"de Castro JC, Wang D, Strakowski J, Emril DR, Chang Chien GC. Alpha-2 macroglobulin for the treatment of neuroma pain in the stump of a below-knee amputee patient. Pain Manag. 2023;13:335\u201341.","journal-title":"Pain Manag"},{"key":"1244_CR140","doi-asserted-by":"publisher","DOI":"10.1016\/j.arthro.2020.12.166","volume":"37","author":"K Thompson","year":"2021","unstructured":"Thompson K, Klein D, Campbell K, Gonzlez-Lomas G, Alaia M, Strauss E, et al. The effectiveness of alpha-2-macroglobulin injections for osteoarthritis of the knee. Arthrosc J Arthrosc Relat Surg. 2021;37: e80.","journal-title":"Arthrosc J Arthrosc Relat Surg"},{"key":"1244_CR141","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40610-020-00142-z","volume":"7","author":"M Zhu","year":"2021","unstructured":"Zhu M, Zhao B, Wei L, Wang S. alpha-2-macroglobulin, a native and powerful proteinase inhibitor, prevents cartilage degeneration disease by inhibiting majority of catabolic enzymes and cytokines. Curr Mol Biol Rep. 2021;7:1\u20137.","journal-title":"Curr Mol Biol Rep"},{"key":"1244_CR142","doi-asserted-by":"publisher","first-page":"2615","DOI":"10.1007\/s00296-011-2010-z","volume":"32","author":"LI Arranz","year":"2012","unstructured":"Arranz LI, Canela M\u00c3, Rafecas M. Dietary aspects in fibromyalgia patients: results of a survey on food awareness, allergies, and nutritional supplementation. Rheumatol Int. 2012;32:2615\u201321.","journal-title":"Rheumatol Int"},{"key":"1244_CR143","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s11255-010-9898-1","volume":"43","author":"K Berger","year":"2011","unstructured":"Berger K, Moeller MJ. Cofilin-1 in the podocyte: a molecular switch for actin dynamics. Int Urol Nephrol. 2011;43:273\u20135.","journal-title":"Int Urol Nephrol"},{"key":"1244_CR144","doi-asserted-by":"publisher","first-page":"46","DOI":"10.2174\/15680096113136660109","volume":"14","author":"G Hamilton","year":"2014","unstructured":"Hamilton G. Cyclophilin A as a target of Cisplatin chemosensitizers. Curr Cancer Drug Targets. 2014;14:46\u201358.","journal-title":"Curr Cancer Drug Targets"},{"key":"1244_CR145","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.proghi.2016.05.001","volume":"51","author":"TR Samatov","year":"2016","unstructured":"Samatov TR, Wicklein D, Tonevitsky AG. L1CAM: Cell adhesion and more. Prog Histochem Cytochem. 2016;51:25\u201332.","journal-title":"Prog Histochem Cytochem"},{"key":"1244_CR146","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.cll.2019.07.006","volume":"39","author":"M Ling","year":"2019","unstructured":"Ling M, Murali M. Analysis of the complement system in the clinical immunology laboratory. Clin Lab Med. 2019;39:579\u201390.","journal-title":"Clin Lab Med"},{"key":"1244_CR147","doi-asserted-by":"publisher","first-page":"4494","DOI":"10.1128\/MCB.00074-08","volume":"28","author":"N Fukazawa","year":"2008","unstructured":"Fukazawa N, Yokoyama S, Eiraku M, Kengaku M, Maeda N. Receptor type protein tyrosine phosphatase zeta-pleiotrophin signaling controls endocytic trafficking of DNER that regulates neuritogenesis. Mol Cell Biol. 2008;28:4494\u2013506.","journal-title":"Mol Cell Biol"},{"key":"1244_CR148","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s12865-020-00355-y","volume":"21","author":"L Liu","year":"2020","unstructured":"Liu L, Guo H, Song A, Huang J, Zhang Y, Jin S, et al. Progranulin inhibits LPS-induced macrophage M1 polarization via NF-\u043aB and MAPK pathways. BMC Immunol. 2020;21:32.","journal-title":"BMC Immunol"},{"key":"1244_CR149","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1111\/1756-185X.12481","volume":"17","author":"L Rani","year":"2014","unstructured":"Rani L, Minz RW, Arora A, Kannan M, Sharma A, Anand S, et al. Serum proteomic profiling in granumomatosis with polyangiitis using two-dimensional gel electrophoresis along with matrix assisted laser desorption ionization time of flight mass spectrometry. Int J Rheum Dis. 2014;17:910\u20139.","journal-title":"Int J Rheum Dis"},{"key":"1244_CR150","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.3233\/JPD-213053","volume":"12","author":"I Lindberg","year":"2022","unstructured":"Lindberg I, Shu Z, Lam H, Helwig M, Yucer N, Laperle A, et al. The proSAAS chaperone provides neuroprotection and attenuates transsynaptic \u03b1-synuclein spread in rodent models of Parkinson\u2019s disease. J Parkinsons Dis. 2022;12:1463\u201378.","journal-title":"J Parkinsons Dis"},{"key":"1244_CR151","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1038\/clpt.2009.87","volume":"86","author":"T Wajima","year":"2009","unstructured":"Wajima T, Isbister GK, Duffull SB. A comprehensive model for the humoral coagulation network in humans. Clin Pharmacol Ther. 2009;86:290\u20138.","journal-title":"Clin Pharmacol Ther"},{"key":"1244_CR152","doi-asserted-by":"publisher","first-page":"418","DOI":"10.5551\/jat.49619","volume":"27","author":"Z Li","year":"2020","unstructured":"Li Z, He C, Liu Y, Wang D, Lin M, Liu C, et al. Association of Fetuin-B with subclinical atherosclerosis in obese Chinese adults. J Atheroscler Thromb. 2020;27:418\u201328.","journal-title":"J Atheroscler Thromb"},{"key":"1244_CR153","first-page":"1914","volume":"31","author":"K Saigo","year":"1990","unstructured":"Saigo K, Yoshida A, Sugano W, Ryo R. Yamaguchi N [Histidine-rich glycoprotein in blood during inflammation, surgical operation or hemodialysis]. Rinsho Ketsueki. 1990;31:1914\u20139.","journal-title":"Rinsho Ketsueki"},{"key":"1244_CR154","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.cytogfr.2019.06.003","volume":"48","author":"Z Wu","year":"2019","unstructured":"Wu Z, Zhang Z, Lei Z, Lei P. CD14: biology and role in the pathogenesis of disease. Cytokine Growth Factor Rev. 2019;48:24\u201331.","journal-title":"Cytokine Growth Factor Rev"},{"key":"1244_CR155","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1002\/prca.201000110","volume":"5","author":"N Piyaphanee","year":"2011","unstructured":"Piyaphanee N, Ma Q, Kremen O, Czech K, Greis K, Mitsnefes M, et al. Discovery and initial validation of \u03b1 1-B glycoprotein fragmentation as a differential urinary biomarker in pediatric steroid-resistant nephrotic syndrome. Proteomics- Clin Appl Clin Appl. 2011;5:334\u201342.","journal-title":"Proteomics- Clin Appl Clin Appl"},{"key":"1244_CR156","doi-asserted-by":"crossref","unstructured":"Lubbers R, Beaart-van de Voorde LJJ, van Leeuwen K, de Boer M, Gelderman KA, van den Berg MJ, et al. Complex medical history of a patient with a compound heterozygous mutation in C1QC. Lupus. 2019;28:1255\u201360.","DOI":"10.1177\/0961203319865029"},{"key":"1244_CR157","doi-asserted-by":"publisher","first-page":"565","DOI":"10.4049\/jimmunol.1701128","volume":"200","author":"AR Victor","year":"2018","unstructured":"Victor AR, Weigel C, Scoville SD, Chan WK, Chatman K, Nemer MM, et al. Epigenetic and posttranscriptional regulation of CD16 expression during human NK cell development. J Immunol. 2018;200:565\u201372.","journal-title":"J Immunol"},{"key":"1244_CR158","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20180649","volume":"217","author":"S Mukhopadhyay","year":"2020","unstructured":"Mukhopadhyay S, Heinz E, Porreca I, Alasoo K, Yeung A, Yang H-T, et al. Loss of IL-10 signaling in macrophages limits bacterial killing driven by prostaglandin E2. J Exp Med. 2020;217: e20180649.","journal-title":"J Exp Med"},{"key":"1244_CR159","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","volume":"5","author":"Y Xie","year":"2020","unstructured":"Xie Y, Su N, Yang J, Tan Q, Huang S, Jin M, et al. FGF\/FGFR signaling in health and disease. Signal Transduct Target Ther. 2020;5:181.","journal-title":"Signal Transduct Target Ther"},{"key":"1244_CR160","doi-asserted-by":"publisher","first-page":"419","DOI":"10.2147\/COPD.S149429","volume":"13","author":"KR Chapman","year":"2018","unstructured":"Chapman KR, Chorostowska-Wynimko J, Koczulla AR, Ferrarotti I, McElvaney NG. Alpha 1 antitrypsin to treat lung disease in alpha 1 antitrypsin deficiency: recent developments and clinical implications. Int J Chron Obstruct Pulmon Dis. 2018;13:419\u201332.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"1244_CR161","doi-asserted-by":"publisher","first-page":"5726","DOI":"10.1021\/acs.biochem.7b00781","volume":"56","author":"LS Cunden","year":"2017","unstructured":"Cunden LS, Brophy MB, Rodriguez GE, Flaxman HA, Nolan EM. Biochemical and functional evaluation of the intramolecular disulfide bonds in the zinc-chelating antimicrobial protein human S100A7 (psoriasin). Biochemistry. 2017;56:5726\u201338.","journal-title":"Biochemistry"},{"key":"1244_CR162","doi-asserted-by":"crossref","unstructured":"Stanly TA, Fritzsche M, Banerji S, Shrestha D, Schneider F, Eggeling C, et al. The cortical actin network regulates avidity-dependent binding of hyaluronan by the lymphatic vessel endothelial receptor LYVE-1. J Biol Chem. 2020;295:5036\u201350.","DOI":"10.1074\/jbc.RA119.011992"}],"container-title":["Current Pain and Headache Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11916-024-01244-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11916-024-01244-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,20]],"date-time":"2024-07-20T05:15:04Z","timestamp":1721452504000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11916-024-01244-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,4,23]]},"references-count":162,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1007\/s11916-024-01244-4","relation":{},"ISSN":["1531-3433","1534-3081"],"issn-type":[{"value":"1531-3433","type":"print"},{"value":"1534-3081","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,4,23]]},"assertion":[{"value":"16 March 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 April 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}